NEW YORK (GenomeWeb) – CombiMatrix today announced that it has signed an agreement under which its suite of diagnostic lab services will be covered by preferred provider organization InterWest Health.
InterWest's network includes over 25,000 hospitals, physicians, and other providers in the northwest US, and contracts with providers in Montana, Idaho, Washington, North Dakota, South Dakota, and Wyoming.
"As we continue to expand our commercial organization into new markets like the Pacific Northwest, it is important for us to partner with comprehensive networks like InterWest," CombiMatrix President and CEO Mark McDonough said in a statement. "This relationship is a result of our continued focus on executing our third-party payor strategy to deliver microarray technologies to doctors and patients nationwide, and enables us to offer our suite of diagnostic services, including CombiSNP Microarray Analysis, to the members of InterWest."
Shares of CombiMatrix were up almost four percent to $2.08 in early morning trading on the Nasdaq.